Flynn D. and Mash D. (1986) Characterization of l-[3H]nicotine
binding in human cerebral cortex: Comparison between Alzheimer's
disease and the normal. J. Neurochem. 47, 1948 –1954.
Gru ̈ nwald F., Biersack H. -J. and Kuchinsky W. (1996) Nicotine
receptor mapping. Eur. J. Nucl. Med. 23, 1012–1013.
Holladay M. W., Wasicak J. T., Lin N. -H., He Y., Ryther K. B., Bannon
A. W., Buckley M. J., Kim D. J. B., Decker M. W., Anderson D. J.,
Campbell J. E., Kuntzweiler T. A., Donnelly-Roberts D. L., PiattoniKaplan M., Briggs C. A., Williams M. and Arneric S. P. (1998)
Identification and initial structure–activity relationship of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally
active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors. J. Med. Chem. 41, 407– 412.
Horti A. G., Koren A. O., Ravert H. T., Musachio J. L., Mathews W. B.,
London E. D. and Dannals R. F. (1998) Synthesis of a radiotracer for
studying nicotinic acetylcholine receptors: 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]A-85380). J. Labelled Compd. Radiopharm.
41, 309 –318.
Horti A. G., Koren A. O., Scheffel U., Kimes A. S., Ravert H. T.,
Mathews W. B., Musachio J. L., Finley P. A., Zhan Y., Dannals R. F. and
London E. D. (1997) 2-[18F]fluoro-3(2(S)-azetidinylmethoxy)pyridine,
a radioligand for in vivo imaging of central nicotinic acetylcholine
receptors. Soc. Neurosci. Abstr. 23, 382.
Kassiou M., Scheffel U. A., Ravert H. T., Mathews W. B., Musachio
J. L., London E. D. and Dannals R. F. (1998) Pharmacologic evaluation
of [11C]A-84543: An enantioselective ligand for in vivo studies of
neuronal nicotinic acetylcholine receptors. Life Sci. 63, 13–18.
Lin N.-H., Gunn D. E., Li Y. H., He Y., Bai H., Ryther K. B.,
Kuntzweiler T., Donnelly-Roberts D. L., Anderson D. J., Campbell J. E.,
Sullivan J. P., Arneric S. P. and Holladay M. W. (1998) Synthesis and
structure–activity relationships of pyridine-modified analogs of
3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic
acetylcholine receptor agonist. Biorganic Med. Chem. Lett. 8, 249 –254.
London E. D., Ball M. J. and Waller S. B. (1989) Nicotinic binding sites
in cerebral cortex and hippocampus in Alzheimer's dementia. Neurochem. Res. 14, 745–750.
Molina P. E., Ding Y.-S., Carroll F. I., Liang F., Volkow N. D., Pappas
N., Kuhar M., Abumrad N., Gatley S. J. and Fowler J. S. (1997)
Fluoro-norchloroepibatidine: preclinical assesment of acute toxicity.
Nucl. Med. Biol. 24,743–747
Musachio J. L., Scheffel U., Finley P. A., Zhan Y., Mochizuki T.,
Wagner H. N. Jr. and Dannals R. F. (1998) 5-[I-123/125]iodo-3-(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in
vivo studies of central nicotinic acetylcholine receptors. Life Sci. 62,
351–357.
Musachio J. L., Scheffel U., Zhan Y., Mochizuki T., Finley P., Xiao Y.,
Da ́vilia-Garc ́ıa M. I., Kellar K. J. and Dannals R. F. (1998) 5-[I-123/
125]iodo-3-(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog
of A-85380 for in vivo studies of nicotinic acetylcholine receptors.
J. Nucl. Med. 39S, 48P.
Musachio J. L., Villemagne V. L., Scheffel U., Stathis M., Finley P.,
Horti A., London E. D. and Dannals R. F. (1997) [125/123I]IPH: A
radioiodinated analog of epibatidine for in vivo studies of nicotinic
acetylcholine receptors. Synapse 26, 392–399.
Musachio J. L., Horti A., London E. D. and Dannals R. F. (1997)
Synthesis of a radioiodinated analog of epibatidine: (6)-exo-2-(2-iodo-5-pyridyl)-7-azabicyclo[2.2.1]heptane for in vitro and in vivo studies of
nicotinic acetylcholine receptors. J. Labelled Compd. Radiopharm. 39,
39 – 48.
Nordberg A., Lundqvist H., Hartig P. Lilja A. and Långstro ̈ m B. (1995)
Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and
Alzheimer brains—In vivo assessment using positron emission tomography. Alzheimer Dis. Assoc. Disord. 9, 21–27.
Norberg A., Alafuzoff I. and Winblad B. (1992) Nicotinic and muscarinic subtypes in the human brain: Changes with aging and dementia.
J. Neurosci. Res. 31, 103–111.
Nyba ̈ck H., Halldin C., Åhlin A., Curvall M. and Eriksson L. (1994)
PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human
brain: Difficulties in visualizing specific receptor binding in vivo.
Psychopharmacology 115, 31–36.
Nyba ̈ck, H., Nordberg A., Långstro ̈m B., Hallidin C., Hartvig P., Åhlin
A., Swahn C.-G. and Sedvall G. (1989) Attempts to visualize nicotinic
receptors in the brain of monkey and man by positron emission
tomography. Prog. Brain Res. 79, 313–319.
Patt J. T., Westera G., Buck A., Fletcher S. R. and Schubiger P. A.
